Gary H Lyman, MD, MPH&quot

Research Reports

Trend in TKI Use, Adherence, and Switching Patterns in Patients With CML: Before and After the Availability of Generic Imatinib

08/19/2020

Gary H. Lyman , MD, MPH, FASCO, FRCP, FACP;

David R. Doody , MS;

Shasank Chennupati , PharmD, MPH;

Eric J. Chow , MD, MPH;

Lena E. Winestone , MD, MSHP;

Henry J. Henk , PhD;

Pamela Morin , MBA;

Jennifer J. Wilkes , MD, MSCE;

Abstract: The therapeutic landscape for chronic myeloid leukemia (CML) has evolved substantially over the past decade, most notably with the introduction of second- and third-generation tyrosine kinase inhibitors...

...

08/19/2020

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Gary H Lyman, MD, MPH&quot

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products